A phase II trial of induction chemotherapy with cisplatin, docetaxel, and capecitabine followed by concurrent cisplatin-radiotherapy in advanced nasopharyngeal carcinoma.

被引：1
|
作者：
Yamouni, M.
Beldjilali, Y.
Benhadji, K. A.
Khellafi, H.
Betkaoui, F.
Kaid, Y.
Benchlef, L.
Daim, F. Z.
Toubal, S.
Boukerche, A.
Abdelaoui, A.
Djellali, L.
机构：
[1] Univ Hosp Oran, Dept Oncol, Oran, Algeria
[2] Univ Hosp Oran, Dept Med Oncol, Oran, Algeria
[3] Univ Hosp Oran, Dept Radiotherapy, Oran, Algeria
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.5543
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5543
引用
收藏
页数：1
相关论文
共 50 条
  • [21] A phase II trial of neoadjuvant chemotherapy with docetaxel/cisplatin/capecitabine in thoracic esophageal squamous cell carcinoma.
    Wu, Xiaobin
    Ling, Jiayu
    Li, Shanshan
    Xiang, Jun
    Deng, Yanhong
    Peng, Junsheng
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [22] Phase Ⅱ study of induction chemotherapy followed by concurrent chemoradiotherapy with raltitrexed and cisplatin in locally advanced nasopharyngeal carcinoma
    Yuan Wu
    Xueyan Wei
    Zilong Yuan
    Hongbin Xu
    Yanping Li
    Ying Li
    Liu Hu
    Guang Han
    Yu Qian
    Desheng Hu
    Chinese Journal of Cancer Research, 2020, 32 (05) : 665 - 672
  • [23] Induction chemotherapy with cisplatin and epirubicin followed by radiotherapy and concurrent cisplatin in locally advanced nasopharyngeal carcinoma observed in a non-endemic population
    Airoldi, Mario
    Gabriele, Anna Maria
    Garzaro, Massimiliano
    Raimondo, Luca
    Condello, Cecilia
    Beatrice, Fabio
    Pecorari, Giancarlo
    Giordano, Carlo
    RADIOTHERAPY AND ONCOLOGY, 2009, 92 (01) : 105 - 110
  • [24] First results of induction chemotherapy with cisplatin, docetaxel, and capecitabine for the treatment of nasopharyngeal carcinoma
    Beldjilali, Y.
    Benhadji, K. A.
    Boukerche, A.
    Khellafi, H.
    Abdelaoui, A.
    Betkaoui, F.
    Tourabi, Z. K.
    Kaid, M. Y.
    Djellali, L.
    Yamouni, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [25] A Phase II study of docetaxel, cisplatin, and 5 FU induction chemotherapy followed by chemoradiotherapy in advanced nasopharyngeal cancer
    Bae, W.
    Cho, S.
    Hwang, J.
    Shim, H.
    Lee, J.
    Lim, S.
    Chung, W.
    Chung, I.
    EJC SUPPLEMENTS, 2009, 7 (02): : 488 - 489
  • [26] Assessment of Concurrent Chemoradiotherapy plus Induction Chemotherapy in Advanced Nasopharyngeal Carcinoma: Cisplatin, Fluorouracil, and Docetaxel versus Gemcitabine and Cisplatin
    Zhen Zeng
    Ruo-Nan Yan
    Li Tu
    Yu-Yi Wang
    Pei-Ran Chen
    Feng Luo
    Lei Liu
    Scientific Reports, 8
  • [27] Assessment of Concurrent Chemoradiotherapy plus Induction Chemotherapy in Advanced Nasopharyngeal Carcinoma: Cisplatin, Fluorouracil, and Docetaxel versus Gemcitabine and Cisplatin
    Zeng, Zhen
    Yan, Ruo-Nan
    Tu, Li
    Wang, Yu-Yi
    Chen, Pei-Ran
    Luo, Feng
    Liu, Lei
    SCIENTIFIC REPORTS, 2018, 8
  • [28] Induction chemotherapy regimen of docetaxel plus cisplatin vs docetaxel, cisplatin plus fluorouracil followed by concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: Preliminary results of a phase III multicenter randomized controlled trial
    He, S.
    Wang, Y.
    Wang, C.
    Peng, Z.
    Chen, Y.
    ANNALS OF ONCOLOGY, 2022, 33 : S1521 - S1521
  • [29] A phase II trial of induction NAB-paclitaxel and cisplatin followed by concurrent chemoradiotherapy in patients with locally advanced nasopharyngeal carcinoma
    Ke, Liang-Ru
    Xia, Wei-Xiong
    Qiu, Wen-Ze
    Huang, Xin-Jun
    Yu, Ya-Hui
    Liang, Hu
    Liu, Guo-Ying
    Xiang, Yan-Qun
    Guo, Xiang
    Lv, Xing
    ORAL ONCOLOGY, 2017, 70 : 7 - 13
  • [30] Overall survival after concurrent cisplatin-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma
    Chan, ATC
    Leung, SF
    Ngan, RKC
    Teo, PML
    Lau, WH
    Kwan, WH
    Hui, EP
    Yiu, HY
    Yeo, W
    Cheung, FY
    Yu, KH
    Chiu, KW
    Chan, DT
    Mok, TSK
    Yau, S
    Yuen, KT
    Mo, FKF
    Lai, MMP
    Ma, BBY
    Kam, MKM
    Leung, TWT
    Johnson, PJ
    Choi, PHK
    Zee, BCY
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (07) : 536 - 539
12345